Atai Life Sciences EBITDA 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Atai Life Sciences ebitda from 2020 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$17.3B
DaVita (DVA)	$13.8B
Encompass Health (EHC)	$9.2B
Chemed (CHE)	$8.7B
Elanco Animal Health (ELAN)	$7.1B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$4.9B
Amedisys (AMED)	$3.2B
Astrana Health (ASTH)	$2.7B
LifeStance Health (LFST)	$2.6B
Addus HomeCare (ADUS)	$2.4B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$1B
Aveanna Healthcare Holdings (AVAH)	$1B
Daxor (DXR)	$46M
ATI Physical Therapy (ATIP)	$26M
MEDIROM Healthcare Technologies (MRM)	$19M
Psychemedics (PMD)	$14M
Ontrak (OTRK)	$10M
Novo Integrated Sciences (NVOS)	$5M
IMAC Holdings (BACK)	$2M